Original language | English |
---|---|
Pages (from-to) | 2627-2631 |
Number of pages | 5 |
Journal | Blood Advances |
Volume | 3 |
Issue number | 17 |
DOIs | |
State | Published - Sep 10 2019 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier. / Bradley, Christian P.; Chen, Cai; Oetjen, Karolyn A.; Yan, Cheng; Panjwani, Reema; Hauffe, Sara; Calvo, Katherine R.; Yuan, Constance; Patel, Prapti Arvind; Montgomery, Nathan D.; Foster, Matthew C.; Battiwalla, Minoo; Barrett, A. John; Gibbons, Richard J.; Ito, Sawa.
In: Blood Advances, Vol. 3, No. 17, 10.09.2019, p. 2627-2631.Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier
AU - Bradley, Christian P.
AU - Chen, Cai
AU - Oetjen, Karolyn A.
AU - Yan, Cheng
AU - Panjwani, Reema
AU - Hauffe, Sara
AU - Calvo, Katherine R.
AU - Yuan, Constance
AU - Patel, Prapti Arvind
AU - Montgomery, Nathan D.
AU - Foster, Matthew C.
AU - Battiwalla, Minoo
AU - Barrett, A. John
AU - Gibbons, Richard J.
AU - Ito, Sawa
N1 - Funding Information: Conflict-of-interest disclosure: N.D.M. received research and travel funding from Ventana Biosystems and collaborated on research with ArcherDx. M.C.F. received an honorarium from Shire Plc and a grant from Bellicum Pharmaceuticals, and his institution received fees from Novartis Pharmaceuticals and Amgen Inc. P.A.P. received honoraria from DAVA Pharmaceuticals, served in a consulting or advisory role for France Foundation, and was a member of the speaker’s bureau for Celgene. The remaining authors declare no competing financial interests.
PY - 2019/9/10
Y1 - 2019/9/10
UR - http://www.scopus.com/inward/record.url?scp=85072206256&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2019000013
DO - 10.1182/bloodadvances.2019000013
M3 - Article
C2 - 31501157
AN - SCOPUS:85072206256
VL - 3
SP - 2627
EP - 2631
JO - Blood advances
JF - Blood advances
SN - 2473-9529
IS - 17
ER -